Dois países na União Europeia/espaço Económico Europeu (UE/EEE) relataram um aumento significativo de casos e prevalência de VIH entre os utilizadores de droga por via injectável (UDI’s) em 2011 (Grécia e România).
Nos últimos anos de debates globais sobre políticas e estratégias sobre drogas controladas, as instituições europeias (Comissão e Conselho Europeu e a EMCDDA) e estados-membro têm sido um factor progressivo e civilizacional para a promoção de programas de políticas de drogas equilibrados, baseados em evidências e humanos.
Este artigo revê o desenvolvimento das abordagens iniciais soviéticas do tratamento de drogas focalizando a luta pelo poder disciplinar entre os principais higienistas sociais e mentais e os psiquiatras clínicos como um momento de definição para a especialidade do tratamento de drogas soviético, que se tornou conhecido como “narcologia”.
Recently, there have been worrying signs that the European institutions are taking a wrong turn in drug policy - the vision and leadership on this issue is notably absent, and some of the recent positions taken seem to indicate a return to the simplistic messages and priorities of the failed policies of the past.
The legal status of cannabis for personal use is one of the most controversial policy issues in the European Union. Although cannabis is a classified narcotic drug placed under control by the United Nations and by all EU Member States, the measures adopted to control it at national level vary considerably.
Harm Reduction International, Youth RISE and the Eurasian Harm Reduction Network have provided the Committee with a submission on drug use, an issue specifically requested by the Committee in its guidance note.
The adoption of national policies that are more aligned with the risks of different drugs and the effectiveness of controls will require the amendment of existing treaties, the formulation of new treaties, or withdrawal of states from existing treaties and re-accession with reservations.
Evidence-based interventions are increasingly being identified that are capable of making drugs less available, reducing violence in drug markets, lessening misuse of legal pharmaceuticals, preventing drug use initiation in young people, and reducing drug use and its consequences in established drug users.
This paper summarises data for the prevalence, correlates, and probable adverse health consequences of problem use of amphetamines, cannabis, cocaine, and opioids. We discuss findings from systematic reviews of the prevalence of illicit drug use and dependence, remission from dependence, and mortality in illicit drug users, and evidence for acute and chronic effects of illicit drug use. We outline the regional and global distribution of use and estimated health burden from illicit drugs
Driven by the rapid spread of HIV, Vietnam’s response to drug use has undergone significant transformation in the past decade. This paper analyses factors that prompted these changes and investigates their impact on the lives of people who use drugs.
